Home
About
Overview
Sharing Data
ORCID
Help
History (7)
Management of Sepsis and Septic Shock
Respiratory guidelines--which real world?
University of Chicago phase II consortium trial of selumetinib (MEKi) demonstrates low tolerability and efficacy in relapsed DLBCL.
Risk of Procedural Hemorrhage.
Phase II study of yttrium-90-ibritumomab tiuxetan in patients with relapsed or refractory mantle cell lymphoma.
See All 7 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Nawas, Mariam
One or more keywords matched the following items that are connected to
Nawas, Mariam
Item Type
Name
Academic Article
Cellular Therapy During COVID-19: Lessons Learned and Preparing for Subsequent Waves.
Concept
Time-to-Treatment
Search Criteria
Time to Treatment